Pfizer-BioNTech Cutting Back Vaccine Deliveries to Canada Due to Production Issues

Pfizer-BioNTech Cutting Back Vaccine Deliveries to Canada Due to Production Issues
A dose of the Pfizer-BioNTech COVID-19 vaccine is prepared at the Michener Institute in Toronto on Dec. 14, 2020. The Canadian Press/Frank Gunn
|Updated:

OTTAWA—Procurement Minister Anita Anand says production issues in Europe will temporarily reduce Pfizer-BioNTech’s ability to deliver vaccines to Canada.

Anand says the U.S. drug-maker is temporarily reducing deliveries because of issues with its European production lines.